Genflow Biosciences plc (LON:GENF – Get Free Report) fell 7.7% during trading on Thursday . The company traded as low as GBX 1.80 and last traded at GBX 1.80. 320,415 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 2,163,648 shares. The stock had previously closed at GBX 1.95.
Genflow Biosciences Price Performance
The firm’s fifty day moving average is GBX 2.02 and its two-hundred day moving average is GBX 2.05. The firm has a market capitalization of £10.20 million, a PE ratio of -5.42 and a beta of 2.30.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
- Astera Labs’ Post-Earnings Pullback May Be Last Chance to Buy Below $360
- McDonald’s Stock Sell-Off: Justified Warning or Buying Opportunity?
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
